Dr. Nupur Lala, MD

Dr. Lala practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Lala's NPI, 1598257891, was assigned on June 1, 2018. Dr. Lala graduated from University of Arkansas College of Medicine in 2018. Dr. Lala holds New Hampshire license 33309.

Dr. Lala's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Lala's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Lala is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Lala to 1 more medical group, named with a free account. Dr. Lala's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lala practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lala's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Lala's licenses on file in 2 states: New Hampshire and Rhode Island.

CMS data shows 13 Medicare services from Dr. Lala across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $985 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Lala in 2024. The largest group is 85 and over, with 0 patients. 54% of them have high blood pressure, and 46% have high cholesterol. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lala's median patient age at 57, with 48% women.

In 2024, Dr. Lala wrote 192 Medicare Part D claims for 70 patients. 98% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $2,787 in total drug cost. In 2023, CMS named 119 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Lala for performance year 2024, reported through an alternative payment model (APM). Dr. Lala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lala as offering telehealth.

Dmand AI links 5 papers to Dr. Lala, published from 2013 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Pituitary Neoplasms. Dr. Lala has published most often in Clin Neurol Neurosurg. Dr. Lala's most frequent co-authors are Saud Alhusaini, MD, PhD, Eliza B. Geer, MD and Andrew Hsu, MD.

CMS Open Payments shows 2 general payments to Dr. Lala from 2 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $170.

Dr. Lala graduated from University of Arkansas College of Medicine in 2018.